Signaling Pathways - Calcium-Activated Potassium (KCa) Channels - 5-HT2 Receptor - SUMOylation - PARP
清除全部
-
A8893 Rucaparib (free base)中文名: 瑞卡帕布Target: PARPSummary: PARP抑制剂 -
B6506 SCH 23390 hydrochlorideTarget: dopamine receptor|5-HT1 Receptor|5-HT2 ReceptorSummary: 多巴胺受体拮抗剂 -
B6347 Methylergometrine maleate中文名: 马来酸甲麦角新碱Target: 5-HT1 Receptor|5-HT2 ReceptorSummary: 5-HT1/5-HT2受体拮抗剂 -
B2191 Dequalinium Chloride中文名: 地喹氯铵Target: PKC|Calcium-Activated Potassium (KCa) ChannelsSummary: PKC抑制剂 -
B1036 MLN49245 CitationTarget: NAE|Ubiquitin-activating Enzyme E1|SUMOylationSummary: NAE抑制剂 -
A8808 ME0328Target: PARPSummary: PARP抑制剂 -
A5354 Zonisamide中文名: 唑尼沙胺Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) ChannelsSummary: 抗惊厥和机械效应的抗癫痫药 -
A1888 TRAM-34Target: Calcium-Activated Potassium (KCa) ChannelsSummary: KCa3.1阻断剂 -
A3958 Veliparib dihydrochloride中文名: 维利帕尼二盐酸盐Target: PARPSummary: PARP-1/PARP-2抑制剂 -
A3729 PJ34Target: PARPSummary: PARP-1抑制剂